Diagnostics

Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity

Company announcement – No. 4 / 2025 Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize...

Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity

WearOptimo Introduces World-Class Advisory Board to Further Advance Microwearable Sensor Technology for Precision Health Monitoring

Distinguished U.S. Experts and Global Industry Leaders Join Newly Formed Advisory Board to Drive Strategic Growth and Innovation BRISBANE, Australia and...

Woodstock Sterile Solutions Invests $8 million in New Automated, High-Speed, State-of-the-Art, Bottle Packaging Line

Investment Reinforces Woodstock’s Commitment to Growth and Operating Efficiency Woodstock Sterile Solutions Woodstock Sterile Solutions is expanding its BFS capabilities...

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma

Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the...

Base Molecular Resonance™ Technologies Announces Breakthrough in DNA Signature Detection, Expanding the Boundaries of Quantum Physics Technology

Revolutionizing Law Enforcement, Medical and Military Applications STUART, Fla., March 10, 2025 /PRNewswire/ -- Base Molecular Resonance™ Technologies (BMRT), a...

HEOR Services Market Size Booms with CAGR 12.3%, Projected to Reach $3.79 Billion by 2031 | Exclusive Report by The Insight Partners

NEW YORK, March 5, 2025 /PRNewswire/ -- According to a comprehensive report from The Insight Partners, "Health Economics and Outcome...

error: Content is protected !!